IFF Wins First Heart Health Claim for Soy Protein in Australia and New Zealand
Event summary
- IFF (NYSE: IFF) secured the first heart health claim for isolated soy protein in Australia and New Zealand from FSANZ.
- The claim links soy protein consumption to healthy blood cholesterol levels, supported by multi-year research.
- Foods with 20-25 grams of isolated soy protein daily can now carry the heart health claim.
- Isolated soy protein is a 90% plant-based, complete protein used in beverages, dairy alternatives, and plant-based foods.
The big picture
IFF's regulatory win in Australia and New Zealand expands its market reach for soy protein, aligning with global trends toward plant-based nutrition and health-focused food products. The approval positions IFF to capitalize on growing consumer demand for functional foods that combine taste, sustainability, and clinically supported benefits. This milestone follows similar recognitions in 11 other countries, underscoring the company's leadership in protein solutions.
What we're watching
- Market Adoption
- How quickly food and beverage manufacturers in Australia and New Zealand integrate the heart health claim into new products.
- Consumer Response
- Whether consumers will prioritize soy protein products with clinically supported heart health benefits.
- Competitive Dynamics
- The pace at which competitors in the plant-based protein space seek similar regulatory approvals in other regions.
Related topics